ClearPoint Neuro CLPT Cash Flow Statement (2011-2026)

NASDAQ CLPT
$11.77 -3.54 (-23.12%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

ClearPoint Neuro Quarterly Cash Flow Statement

Periods 57 quarters
Latest Jun 2026

ClearPoint Neuro reported cash from operations of -$7.00M and free cash flow of -$7.21M for the quarter ended Jun 2026, down 174.3% year over year. This cash flow statement covers 57 quarters of results from Mar 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-4.04M-4.15M-3.97M-4.29M-3.79M-4.47M-5.71M-7.13M-4.90M-4.71M-4.15M-4.41M-4.97M-5.39M-6.03M-5.84M-5.89M-7.79M-9.55M-11.34M
Depreciation and DepletionDep. & Depletion
Share-based CompensationStock Comp.
0.59M0.93M0.90M0.88M1.18M1.17M1.31M1.65M1.58M1.54M1.50M1.80M1.90M1.70M1.91M2.27M2.02M1.98M2.22M2.27M
Gains from Sales and DivestituresGains Divest
Cash from OperationsCash from Ops.
-3.30M-3.55M-4.27M-4.98M-3.85M-3.06M-5.68M-5.08M-1.80M-1.17M-3.84M-2.67M-1.20M-1.24M-6.17M-2.55M-3.12M-12.05M-8.00M-7.00M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.50M0.50M
Depreciation & Amortization (CF)Dep. & Amort.
0.13M0.13M0.13M0.13M0.13M0.13M0.14M0.18M0.27M0.24M0.24M0.23M0.26M0.24M0.23M0.27M0.32M0.43M0.52M0.72M
Change in Working Capital
Change in ReceivablesChange Receivables
0.23M-0.19M-0.15M1.16M-0.02M-0.77M0.18M0.40M0.07M1.14M-0.85M0.60M0.40M1.05M-0.85M0.61M-0.26M0.77M2.02M-0.27M
Change in InventoryChange Inventory
0.38M1.03M0.88M0.91M1.53M1.10M0.58M-0.67M-0.17M-0.98M-0.05M0.37M-0.75M-0.31M-0.08M-0.40M0.50M0.09M0.12M0.33M
Change in Accured ExpensesChange Accured Exp.
0.11M-0.13M-0.69M1.37M0.58M0.34M-0.96M0.68M-0.74M0.37M-0.93M1.66M0.65M1.73M-2.88M0.94M0.69M-6.27M-0.44M1.21M
Other Working Capital ChangesOther WC Changes
-0.16M-0.34M-0.13M1.14M0.14M0.07M-0.15M-0.33M-0.07M2.25M-1.46M-0.17M0.21M0.55M-0.58M0.01M-0.14M-0.30M-0.65M-0.25M
Investing Activities
Capital ExpendituresCapex
0.12M0.04M0.07M0.08M0.07M0.04M0.14M0.32M0.23M0.02M0.01M0.26M0.18M0.09M0.20M0.05M0.65M0.21M
Change in IntangiblesChange Intangibless
0.12M0.56M0.21M0.17M0.17M
Cash from Investing ActivitiesCash from Investing
-0.12M-0.04M-0.18M-21.67M-0.63M11.75M-0.14M9.51M-0.23M-0.19M-0.01M-0.26M-0.18M-0.09M-0.20M1.09M-0.65M-0.21M
Financing Activities
Other financing activitiesOther financing
0.06M0.34M0.01M0.08M0.09M0.04M0.15M0.13M0.06M0.08M1.30M0.36M0.20M1.99M
Cash from Financing ActivitiesCash from Financing
-0.45M0.05M0.00M0.51M-0.33M0.22M-0.01M0.24M-0.09M0.15M16.05M0.16M-10.06M0.04M-1.36M31.98M19.56M-1.84M1.00M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
0.26M0.22M0.31M0.19M-0.03M0.02M3.24M0.15M0.46M
Additional items
Change in Cash
-3.87M-3.54M-4.45M-26.13M-4.81M8.90M-5.82M4.67M-2.12M-1.20M12.21M-2.51M-11.27M-1.47M-7.72M29.33M-3.32M8.57M-10.46M-6.23M
Free Cash FlowFCF
-3.42M-3.59M-4.34M-5.06M-3.92M-3.10M-5.82M-5.40M-2.03M-1.19M-3.84M-2.67M-1.21M-1.51M-6.36M-2.64M-3.32M-12.10M-8.64M-7.21M
Net Cash FlowNCF
-3.87M-3.54M-4.45M-26.13M-4.81M8.90M-5.82M4.67M-2.12M-1.20M12.21M-2.51M-11.27M-1.47M-7.72M29.33M-3.32M8.60M-10.49M-6.21M

ClearPoint Neuro Cash Flow Statement API

Pull ClearPoint Neuro's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLPT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY